Article info
PDFBackground
Paper
Why cure, why now?
- Correspondence to Dr Daniel R Kuritzkes, Division of Infectious Diseases, Brigham and Women's Hospital, Boston MA, 02139 USA; dkuritzkes{at}partners.org
Citation
Why cure, why now?
Publication history
- Received April 7, 2016
- Accepted May 3, 2016
- First published June 7, 2016.
Online issue publication
October 31, 2022
Article Versions
- Previous version (31 October 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Other content recommended for you
- HIV associated pulmonary emphysema: a review of the literature and inquiry into its mechanism
- Cardiovascular manifestations of HIV infection
- Pathogenesis of Anemia During Human Immunodeficiency Virus Infection
- Diminished frequency of hepatitis C virus specific interferon γ secreting CD4+ T cells in human immunodeficiency virus/hepatitis C virus coinfected patients
- Monitoring patients with HIV disease
- Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection
- Increased polymorphonuclear leucocyte rigidity in HIV infected individuals
- Allergy, immunity, and infection
- Major advances in the treatment of HIV-1 infection
- Human immunodeficiency virus associated spondyloarthropathy: pathogenic insights based on imaging findings and response to highly active antiretroviral treatment